BofA Securities Starts Ocular Therapeutix (OCUL) at Buy, 'Inserting a new option for wAMD'
Tweet Send to a Friend
(Updated - February 9, 2024 7:52 AM EST)
BofA Securities analyst Tazeen Ahmad initiates coverage on Ocular Therapeutix (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Tazeen Ahmad initiates coverage on Ocular Therapeutix (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
